| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.08 | 0.2 |